<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00197743</url>
  </required_header>
  <id_info>
    <org_study_id>HD32257</org_study_id>
    <nct_id>NCT00197743</nct_id>
  </id_info>
  <brief_title>Trial of Vitamins in HIV Progression and Transmission</brief_title>
  <official_title>Trial of Vitamins in HIV Progression and Transmission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muhimbili University of Health and Allied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tested the hypothesis that multivitamin supplementation given to HIV+ pregnant
      women in Tanzania would slow disease progression and enhance their overall health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we sought to examine whether the administration of multivitamins excluding
      vitamin A, multivitamins including vitamin A, or vitamin A alone would reduce the risk of
      perinatal transmission of HIV and slow the rate of disease progression in a group of pregnant
      HIV infected women. We also examined the efficacy of the supplements on pregnancy outcomes,
      and risks of maternal and child morbidity and wasting.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1995</start_date>
  <completion_date type="Actual">August 2003</completion_date>
  <primary_completion_date type="Actual">August 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To examine the effect of multivitamin and/or Vitamin A supplements on the risk of perinatal transmission of HIV and rate of HIV disease progression</measure>
    <time_frame>until the end of follow-up in August, 2003</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To examine the effect of multivitamin and/or Vitamin A supplements on child and maternal morbidity, child growth and child mortality</measure>
    <time_frame>until the end of follow-up in August 2003</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1085</enrollment>
  <condition>HIV Infections</condition>
  <condition>Disease Transmission, Vertical</condition>
  <arm_group>
    <arm_group_label>Vitamin A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin A + Beta Carotene</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multivitamins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamins B, C, and E</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin A + Multivitamins</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin A + Beta Carotene, Vitamins B, C, and E</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A + Beta Carotene</intervention_name>
    <description>one daily oral dose of 30 mg beta-carotene + 5000 IU preformed vitamin A</description>
    <arm_group_label>Vitamin A</arm_group_label>
    <arm_group_label>Vitamin A + Multivitamins</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamins</intervention_name>
    <description>one daily oral dose of 20 mg thiamine (vitamin B-1), 20 mg riboflavin (vitamin B-2), 25 mg vitamin B-6, 100 mg niacin, 50 ug cobalamin (vitamin B-12), 500 mg vitamin C, 30 mg vitamin E, and 0.8 mg folic acid</description>
    <arm_group_label>Multivitamins</arm_group_label>
    <arm_group_label>Vitamin A + Multivitamins</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo pill</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-infected women presenting to antenatal care between 12 and 27 weeks of gestation:

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wafaie W Fawzi, MD,DrPh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harvard School of Public Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004 Jul 1;351(1):23-32.</citation>
    <PMID>15229304</PMID>
  </results_reference>
  <results_reference>
    <citation>Fawzi WW, Msamanga GI, Hunter D, Renjifo B, Antelman G, Bang H, Manji K, Kapiga S, Mwakagile D, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS. 2002 Sep 27;16(14):1935-44.</citation>
    <PMID>12351954</PMID>
  </results_reference>
  <results_reference>
    <citation>Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):246-54.</citation>
    <PMID>10839660</PMID>
  </results_reference>
  <results_reference>
    <citation>Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, Kapiga S, Willett W, Hunter DJ. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet. 1998 May 16;351(9114):1477-82.</citation>
    <PMID>9605804</PMID>
  </results_reference>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>November 9, 2010</last_update_submitted>
  <last_update_submitted_qc>November 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Wafaie Fawzi</name_title>
    <organization>Harvard School of Public Health</organization>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Multivitamins</keyword>
  <keyword>Pregnancy outcomes</keyword>
  <keyword>Tanzania</keyword>
  <keyword>Women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Beta Carotene</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
    <mesh_term>Carotenoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

